We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4905Q Marchpole Holdings PLC 03 October 2003 Embargoed until 8.00 am 3 October 2003 Marchpole Holdings plc (the "Company") Capital reduction On 1 September 2003 Marchpole Holdings plc announced that shareholders had approved at an EGM of the same date a proposed reduction of share capital of the Company and of amounts standing to the Company's share premium account in order to eliminate in full the deficit on the Company's profit and loss account as at 31 March 2003. This process has been undertaken as part of the Board's commitment to return to the payment of a dividend at the earliest practicable opportunity. The proposed reduction of share capital and amounts standing to the Company's share premium account remain conditional on the approval of the High Court. The proposed reduction, if approved by the High Court, will comprise a reduction of #22,696,368.11 by means of the cancellation of the entire class of 2,269,636,811 deferred shares of 1p each and the reduction of amounts standing to the Company's share premium account by #14,070,000. The number of ordinary shares in issue and the amount paid up on each such share will not be affected by the proposed reduction. A hearing date at which the High Court will consider the proposed reduction has been set for 15 October 2003. If approved, the capital reduction is expected to become effective shortly thereafter in October. A further announcement will be made after the hearing. Enquiries: Marchpole Holdings Justin Hampshire 020 7908 7777 Shore Capital Simon Edwards 020 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange END CARMTBPTMMMMBRJ
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions